Related references
Note: Only part of the references are listed.Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials
Stephan von Haehling et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Endpoints in Heart Failure Drug Development History and Future
Mona Fiuzat et al.
JACC-HEART FAILURE (2020)
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study
Bernadet T. Santema et al.
LANCET (2019)
Sex differences in heart failure
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2019)
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women
Pooja Dewan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction A Secondary Analysis of 2 Randomized Clinical Trials
Yashashwi Pokharel et al.
JAMA CARDIOLOGY (2017)
Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial
Andrew P. Ambrosy et al.
AMERICAN HEART JOURNAL (2017)
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
Adriaan A. Voors et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Utility of Patient-Reported Outcome Instruments in Heart Failure
Anita A. Kelkar et al.
JACC-HEART FAILURE (2016)
Cardiovascular Health: The Importance of Measuring Patient-Reported Health Status A Scientific Statement From the American Heart Association
John S. Rumsfeld et al.
CIRCULATION (2013)
Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)
Siobhan Gallanagh et al.
CARDIOVASCULAR DRUGS AND THERAPY (2011)
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study
Inger Ekman et al.
EUROPEAN HEART JOURNAL (2011)
A review of health utilities using the EQ-5D in studies of cardiovascular disease
Matthew T. D. Dyer et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
Quality of Life and Depressive Symptoms in the Elderly: A Comparison Between Patients With Heart Failure and Age- and Gender-Matched Community Controls
Ivonne Lesman-Leegte et al.
JOURNAL OF CARDIAC FAILURE (2009)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Monitoring clinical changes in patients with heart failure: A comparison of methods
J Spertus et al.
AMERICAN HEART JOURNAL (2005)
Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
E O'Meara et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Effect of valsartan on quality of life when added to usual therapy for heart failure: Results from the Valsartan Heart Failure Trial
G Majani et al.
JOURNAL OF CARDIAC FAILURE (2005)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Å Hjalmarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)